- United States
- /
- Tech Hardware
- /
- NYSE:INFQ
Infleqtion (INFQ) Is Down 15.9% After DARPA Multistaq Award And $1.11B Shelf Filing - Has The Bull Case Changed?
- Earlier in April 2026, Infleqtion, Inc. announced a US$2 million DARPA HARQ program contract to develop Multistaq, a heterogeneous quantum platform enabling “write-once, target-all” quantum applications across multiple hardware modalities with support from partners including the University of Chicago.
- On top of this, Infleqtion also filed a US$1.11 billion shelf registration for common stock tied to an ESOP-related offering, underscoring both its capital-raising flexibility and emphasis on employee ownership as it advances quantum computing, sensing and timing technologies.
- We’ll now examine how the DARPA-backed Multistaq development could influence Infleqtion’s investment narrative around quantum architectures and government programs.
AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Infleqtion Investment Narrative Recap
To own Infleqtion, you need to believe neutral atom quantum systems and related software can win meaningful roles in defense, timing and high performance computing, despite the company’s small, loss making base. The DARPA HARQ Multistaq award modestly supports the thesis around Infleqtion’s cross hardware software stack, while the ESOP related US$1.11 billion shelf filing expands financial flexibility; neither appears to change the near term focus on securing larger, longer duration government and commercial contracts or the key risk from funding shifts.
Among recent announcements, the Tiqker quantum optical clock integration with Safran’s timing systems is especially relevant, because it shows Infleqtion pushing its sensing and timing portfolio into concrete, GPS free timing use cases. Alongside DARPA’s HARQ program, this reinforces how government and infrastructure programs could act as important demand catalysts for quantum timing, even as investors weigh the company’s cash burn, limited scale at US$32.5 million of 2025 revenue and reliance on public sector budgets.
Yet behind these government wins and product milestones, investors still need to be aware of the risk that...
Read the full narrative on Infleqtion (it's free!)
Infleqtion's narrative projects $74.6 billion revenue and $9.4 billion earnings by 2029. This requires 1219.4% yearly revenue growth and about a $9.4 billion earnings increase from -$31.8 million today.
Uncover how Infleqtion's forecasts yield a $22.00 fair value, a 74% upside to its current price.
Exploring Other Perspectives
Two fair value estimates from the Simply Wall St Community cluster tightly around US$21 to US$22 per share, showing how even a small sample can reflect differing conviction levels. You should weigh those views against the concentration of Infleqtion’s revenue in government and defense programs, since any change in long term funding priorities could matter more than short term contract headlines.
Explore 2 other fair value estimates on Infleqtion - why the stock might be worth as much as 74% more than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Infleqtion research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Infleqtion research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Infleqtion's overall financial health at a glance.
Interested In Other Possibilities?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- The latest GPUs need a type of rare earth metal called Neodymium and there are only 31 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Gold miners still look inexpensive because the market thinks we're near the top of the cycle. Given what's happening to the dollar, I'm not so sure.

Is it a safer bet on gold to have just exposure to ETFs?
Between 2003 and 2011, gold nearly went 5x. Dollar went weak too. The gold companies did bad. It is worth noting that between 2003 and 2011, there was 2008! I will leave it your inference and research.
About NYSE:INFQ
Infleqtion
Engages in the development and commercialization of quantum technology products in the United States, Europe, and Asia.
Flawless balance sheet with moderate risk.